Global Vaccine Market (2020 to 2024) - Size & Forecasts with Impact Analysis of COVID-19 -

DUBLIN--()--The "Global Vaccine Market: Size & Forecasts with Impact Analysis of COVID-19 (2020-2024)" report has been added to's offering.

This report provides an in-depth analysis of the global vaccine market by value, by disease, by type, by patient type, by region, etc. The report provides a regional analysis of the vaccine market, including the following regions: North America (the US & Rest of North America), Europe, Asia Pacific (China, Japan, India & Rest of Asia Pacific), Latin America and the Middle East and Africa. The report also provides a detailed analysis of the COVID-19 impact on the vaccine market.

The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global vaccine market has also been forecasted for the period 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

The global vaccine market is highly dominated with few major market players operating worldwide. The manufacturers of vaccines produce different types of vaccines for different diseases and for the patients of different age group. Further, key players of the vaccine market are GlaxoSmithKline plc, Merck & Co., Inc., Sanofi S.A. (Sanofi Pasteur), and Pfizer Inc. are also profiled with their financial information and respective business strategies.

Vaccines are substances that inject a weakened form of the disease into a person's body, to stimulate the production of antibodies and to provide immunity against infectious diseases. While drugs are administered to patients to treat medical problems, vaccines are administered to healthy children or adults to prevent infectious diseases. Vaccines can be injected through a needle; taken by mouth; and inhaled through the nose. A vaccine is considered to be very important, as it protects children from serious complications of preventable diseases. Vaccines are also safe and effective, as it is carefully reviewed by the scientists, doctors and researchers in different phases and trials. Vaccines are also proved beneficial in protecting future generations because they reduce or may have eliminated the impact of many diseases that killed people just a few generations ago.

There are four main types of vaccines: Live-attenuated vaccines, Inactivated Vaccines, Recombinant/Conjugate/Subunit Vaccines, and Toxoid Vaccines. Vaccines have a long history with continuously evolving premium and new generation vaccines. The vaccine market can be segmented on the basis of disease, type, route of administration, patient type, and end-users.

Key Topics Covered:

1. Executive Summary

2. Introduction

2.1 Vaccine: An Overview

2.1.1 Importance of Vaccine

2.1.2 History of Vaccine

2.1.3 Types of Vaccines

2.2 Vaccine Segmentation: An Overview

2.2.1 Vaccine Segmentation by Disease

2.2.2 Vaccine Segmentation by Type and Route of Administration

2.2.3 Vaccine Segmentation by Patient Type and End-users

3. Global Market Analysis

3.1 Global Vaccine Market: An Analysis

3.2 Global Vaccine Market: Disease Analysis

3.3 Global Vaccine Market: Type Analysis

3.4 Global Vaccine Market: Patient Type Analysis

4. Regional Market Analysis

4.1 North America Vaccine Market: An Analysis

4.2 Europe Vaccine Market: An Analysis

4.3 Asia Pacific Vaccine Market: An Analysis

4.4 Latin America Vaccine Market: An Analysis

4.5 Middle East and Africa Vaccine Market: An Analysis

5. Market Dynamics

5.1 Growth Driver

5.1.1 Increasing Prevalence of Infectious Diseases

5.1.2 Rising Focus on Immunization

5.1.3 Growing Population

5.1.4 Escalating Healthcare Spending

5.1.5 Surge in the Use of Adjuvants

5.1.6 Rising Initiatives by the Government and Non-Government Organizations

5.2 Challenges

5.2.1 Inadequate Access to Vaccines

5.2.2 Stringent Regulations

5.3 Market Trends

5.3.1 Growing Popularity of Next-generation Vaccines

5.3.2 Increasing Demand for Adult Vaccines

5.3.3 Surge in the Use of Therapeutic Vaccines

5.3.4 Impact of COVID-19 Outbreak

6. Competitive Landscape

6.1 Global Vaccine Players by Market Share

6.2 Global Vaccine Market Players by Major Merger & Acquisition (M&A) Deals

6.3 Global Vaccine Market Players by Vaccine Pipelines

6.4 Global Vaccine Market Players by Vaccines in the Pipelines for COVID-19

7. Company Profiles

7.1 GlaxoSmithKline plc

7.1.1 Business Overview

7.1.2 Financial Overview

7.1.3 Business Strategy

7.2 Merck & Co., Inc.

7.3 Sanofi S.A. (Sanofi Pasteur)

7.4 Pfizer Inc.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900